Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by himmleron Mar 30, 2018 5:27pm

145 Views

Post# 27809040

RE:RE:RE:Don’t forget 13 million shares where bought from

Clearity...trade total..small %Canada...Small % overall...but higher than normal.

Date	Ex	Sym	Open	High	Low	Close	Chg	Total Vol	#Tr	Bid	Ask	T-TSX	A-Alpha	X-Chi-X	H-CX2	P-Pure	O-Omega	M-TriAct	L-LiquidNet	I-Instinet	Y-Lynx	U-Aequitas NEO
2018-03-29	T	PLI	1.00	1.00	0.86	0.88	-0.36	30,065,254	10,183	0.87	0.88	13,320,816	3,007,309	4,060,300	1,617,203	2,704,826	545,100	1,572,000			1,500	3,236,200